QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

About this update from Qiagen N.v.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/4c374b00da9aec5e8f12ed437d359319"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8H5xo8x4P_BySbjLZwS9Kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4c374b00da9aec5e8f12ed437d359319","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Stephen H. Rusckowski elected as Chairman of the Supervisory Board after AGM; former Chairman Lawrence A. Rosen did not stand for re-election following 12 years of service","length":171,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Shareholders approve all resolutions at AGM – including first-ever annual cash dividend and a synthetic share repurchase authorization of up to $500 million","length":156,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":327,"olType":false},{"type":"text","content":"VENLO, Netherlands, June 26, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board has elected Stephen H. Rusckowski as Chairman following the Annual General Meeting of Shareholders (AGM) on June 26, 2025.","length":273,"tagName":"p"},{"type":"text","content":"He succeeds Lawrence A. Rosen, who did not stand for re-election after serving for 12 years on the Supervisory Board. The Dutch Corporate Governance Code indicates that Directors of public companies should not serve more than 12 years for a company on their Supervisory Board.","length":276,"tagName":"p"},{"type":"text","content":"At the AGM, where 80.4% of QIAGEN’s issued shares were represented, shareholders approved all proposed resolutions, including the initiation of an annual cash dividend and a new share repurchase authorization of up to $500 million.","length":231,"tagName":"p"},{"type":"text","content":"Mr. Rusckowski joined the Supervisory Board in 2023 and has served as Chairman of the Nomination & Governance Committee and as a member of the Human Resources & Compensation Committee. He brings deep global healthcare and leadership experience, having previously served as Chairman, President and CEO of Quest Diagnostics and as CEO o...

More updates from Qiagen N.v.